naringenin has been researched along with Cancer of Head in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, TM; Chen, PH; Lee, CJ; Lin, JS; Liu, JF; Tsai, YJ; Wu, HM | 1 |
| Gong, ZC; Li, CX; Tan, XR | 1 |
2 other study(ies) available for naringenin and Cancer of Head
| Article | Year |
|---|---|
Naringenin induces endoplasmic reticulum stress-mediated cell apoptosis and autophagy in human oral squamous cell carcinoma cells.
Topics: Apoptosis; Autophagy; Carcinoma, Squamous Cell; Endoplasmic Reticulum Stress; Head and Neck Neoplasms; Humans; Mouth Neoplasms; Reactive Oxygen Species; Squamous Cell Carcinoma of Head and Neck | 2022 |
Considerations regarding the tumor-suppressor role of naringenin as a novel agent for the treatment of oral squamous cell carcinoma.
Topics: Carcinoma, Squamous Cell; Cell Line, Tumor; Head and Neck Neoplasms; Humans; Mouth Neoplasms; Squamous Cell Carcinoma of Head and Neck | 2023 |